Orthofix Medical Inc. (OFIX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $1k
- Sep 1 · Routine
- Form 4 sales
- 114
- On record
- Form 144 notices
- 5
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planMar 5 2026
Sold 12,220 shares at $12.74 ($156k)
Calafiore Massimo, President & CEO
No 10b5-1 planSold 3.7% of holdings ($4.2M position)320,136 shares leftFiling
- 2 Form 4 saleNo planMar 5 same day
Sold 2,312 shares at $12.74 ($29k)
Vitale Lucas, CP&BOO
No 10b5-1 planSold 1.4% of holdings ($2.1M position)164,718 shares leftFiling
- 3 Form 4 saleNo planMar 5 same day
Sold 4,788 shares at $12.74 ($61k)
Andrews Julie, CFO
No 10b5-1 planSold 5.1% of holdings ($1.2M position)88,746 shares leftFiling
- 4 Form 4 saleNo planMar 17 +12 days
Sold 4,269 shares at $11.92 ($51k)
Vitale Lucas, CP&BOO
No 10b5-1 planSold 2.6% of holdings ($2M position)160,449 shares leftFiling
- 5 Form 4 saleNo planApr 16 +30 days
Sold 3,743 shares at $12.82 ($48k)
Cedron Jorge Andres, CLO
No 10b5-1 planSold 6% of holdings ($804k position)59,006 shares leftFiling
- 6 Form 4 saleNo planJun 18 +63 days
Sold 3,670 shares at $9.38 ($34k)
McPherron Aviva, Pres, Global Ops & Qual
No 10b5-1 planSold 5.2% of holdings ($657k position)66,330 shares leftFiling
- 7 Form 4 saleNo planAug 18 +61 days
Sold 1,295 shares at $10.09 ($13k)
Fisher Patrick, President, Global Limb Recon
No 10b5-1 planSold 2.5% of holdings ($530k position)51,219 shares leftFiling
- 8 Form 4 saleRoutineSep 1 +14 days
Sold 150 shares at $9.39 ($1k)
Fisher Patrick, President, Global Limb Recon
10b5-1 planSold 0.3% of holdings ($481k position)51,069 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (119)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Fisher Patrick | President, Global Limb Recon | Form 4 sale | 150 | $1k | 0.3% | Routine | SEC |
| Aug 18, 2026 | Fisher Patrick | President, Global Limb Recon | Form 4 sale | 1,295 | $13k | 2.5% | No plan | SEC |
| Jun 18, 2026 | McPherron Aviva | Pres, Global Ops & Qual | Form 4 sale | 3,670 | $34k | 5.2% | No plan | SEC |
| Apr 16, 2026 | Cedron Jorge Andres | CLO | Form 4 sale | 3,743 | $48k | 6.0% | No plan | SEC |
| Mar 17, 2026 | Vitale Lucas | CP&BOO | Form 4 sale | 4,269 | $51k | 2.6% | No plan | SEC |
| Mar 5, 2026 | Andrews Julie | CFO | Form 4 sale | 4,788 | $61k | 5.1% | No plan | SEC |
| Mar 5, 2026 | Vitale Lucas | CP&BOO | Form 4 sale | 2,312 | $29k | 1.4% | No plan | SEC |
| Mar 5, 2026 | Calafiore Massimo | President & CEO | Form 4 sale | 12,220 | $156k | 3.7% | No plan | SEC |
| Mar 5, 2026 | Fisher Patrick | President, Global Limb Recon | Form 4 sale | 1,536 | $20k | 2.9% | No plan | SEC |
| Mar 5, 2026 | McPherron Aviva | Pres, Global Ops & Qual | Form 4 sale | 2,559 | $33k | 3.6% | No plan | SEC |
| Mar 5, 2026 | Reinhardt Max | President, Global Spine | Form 4 sale | 2,133 | $27k | 7.8% | No plan | SEC |
| Mar 5, 2026 | Cedron Jorge Andres | CLO | Form 4 sale | 2,775 | $35k | 4.2% | No plan | SEC |
| Jan 16, 2026 | Andrews Julie | CFO | Form 4 sale | 4,873 | $70k | 7.7% | No plan | SEC |
| Jan 12, 2026 | Calafiore Massimo | President & CEO | Form 4 sale | 19,397 | $301k | 8.2% | No plan | SEC |
| Aug 18, 2025 | Fisher Patrick | President, Global Orthopedics | Form 4 sale | 1,996 | $28k | 6.2% | No plan | SEC |
| Jun 18, 2025 | McPherron Aviva | Pres, Global Ops & Qual | Form 4 sale | 3,728 | $39k | 7.4% | No plan | SEC |
| Jun 11, 2025 | Reinhardt Max | President, Global Spine | Form 4 sale | 1,643 | $19k | 5.6% | No plan | SEC |
| Apr 16, 2025 | Cedron Jorge Andres | CLO | Form 4 sale | 3,816 | $51k | 8.2% | No plan | SEC |
| Apr 2, 2025 | Gillespie Geoffrey C | CAO | Form 4 sale | 76 | $1k | 0.2% | No plan | SEC |
| Mar 18, 2025 | Vitale Lucas | CP&BOO | Form 4 sale | 4,287 | $71k | 3.1% | No plan | SEC |
| Mar 18, 2025 | Gillespie Geoffrey C | CAO | Form 4 sale | 296 | $5k | 0.7% | No plan | SEC |
| Feb 4, 2025 | Gillespie Geoffrey C | CAO | Form 4 sale | 954 | $17k | 2.4% | No plan | SEC |
| Jan 16, 2025 | Andrews Julie | CFO | Form 4 sale | 4,655 | $83k | 14.1% | No plan | SEC |
| Jan 13, 2025 | Calafiore Massimo | President & CEO | Form 4 sale | 19,281 | $327k | 13.4% | No plan | SEC |
| Jan 13, 2025 | Gillespie Geoffrey C | CAO | Form 4 sale | 475 | $8k | 1.2% | No plan | SEC |
| Jan 8, 2025 | Gillespie Geoffrey C | CAO | Form 4 sale | 476 | $8k | 1.2% | No plan | SEC |
| Dec 17, 2024 | Gillespie Geoffrey C | CAO | Form 4 sale | 26 | $464 | 0.1% | No plan | SEC |
| Dec 21, 2023 | Valentine Keith | Director | Form 144 notice | 66,665 | $926k | Notice | SEC | |
| Nov 20, 2023 | Bostjancic John J. | Officer | Form 144 notice | 33,456 | $368k | Notice | SEC | |
| Nov 9, 2023 | Bostjancic John J. | Officer | Form 144 notice | 9,084 | $98k | Notice | SEC | |
| Nov 9, 2023 | Keran Patrick L | Officer | Form 144 notice | 28,985 | $319k | Notice | SEC | |
| May 26, 2023 | Kenny Kevin J. | President of Global Spine | Form 4 sale | 8,243 | $157k | 5.5% | No plan | SEC |
| May 24, 2023 | Kenny Kevin J. | Officer | Form 144 notice | 10,119 | $192k | Notice | SEC | |
| Mar 10, 2023 | Maniar Shweta | Director | Form 4 sale | 4,262 | $76k | 17.5% | No plan | SEC |
| Jun 5, 2020 | Finegan Michael | Chief Strategy Officer | Form 4 sale | 8,750 | $327k | 15.4% | Plan not stated | SEC |
| Aug 28, 2019 | Mason Brad | CEO | Form 4 sale | 5,805 | $296k | 3.4% | Plan not stated | SEC |
| Jun 13, 2019 | Mason Brad | CEO | Form 4 sale | 8,890 | $454k | 5.4% | Unusual | SEC |
| May 14, 2019 | Mason Brad | CEO | Form 4 sale | 10,668 | $573k | 6.1% | Unusual | SEC |
| Apr 17, 2019 | Mason Brad | CEO | Form 4 sale | 5,949 | $311k | 3.3% | Plan not stated | SEC |
| Feb 19, 2019 | Bianchi Davide | President, Global Extremities | Form 4 sale | 24,400 | $1.6M | 54.1% | Unusual | SEC |
| Jan 15, 2019 | Mason Brad | CEO | Form 4 sale | 5,000 | $251k | 3.6% | Plan not stated | SEC |
| Nov 5, 2018 | Niemann Bradley V. | President of Global Spine | Form 4 sale | 387 | $24k | 1.5% | Plan not stated | SEC |
| Nov 2, 2018 | Faulstick Luke T | Director | Form 4 sale | 8,450 | $516k | 56.6% | Unusual | SEC |
| Nov 2, 2018 | Elting Kimberley A. | Chief Legal & Admin Officer | Form 4 sale | 7,000 | $427k | 30.8% | Unusual | SEC |
| Nov 2, 2018 | Doug Rice | CFO | Form 4 sale | 6,057 | $371k | 18.7% | Plan not stated | SEC |
| Oct 11, 2018 | Doug Rice | CFO | Form 4 sale | 3,949 | $220k | 10.9% | Plan not stated | SEC |
| Sep 5, 2018 | Mason Brad | CEO | Form 4 sale | 2,500 | $133k | 1.7% | Plan not stated | SEC |
| Aug 7, 2018 | Mason Brad | CEO | Form 4 sale | 2,500 | $133k | 1.6% | Plan not stated | SEC |
| Jul 10, 2018 | Mason Brad | CEO | Form 4 sale | 2,500 | $147k | 1.8% | Plan not stated | SEC |
| Jul 3, 2018 | Niemann Bradley V. | President of Global Spine | Form 4 sale | 11,250 | $641k | 29.4% | Unusual | SEC |
| Jun 20, 2018 | Fujikawa Raymond | President Spine Fixation | Form 4 sale | 32,243 | $1.9M | 71.5% | Unusual | SEC |
| Jun 19, 2018 | Bianchi Davide | President Extremity Fixation | Form 4 sale | 14,762 | $886k | 26.4% | Unusual | SEC |
| Jun 18, 2018 | Finegan Michael | Chief Strategy Officer | Form 4 sale | 30,000 | $1.8M | 44.9% | Unusual | SEC |
| Jun 14, 2018 | Mason Brad | CEO | Form 4 sale | 2,500 | $145k | 1.7% | Plan not stated | SEC |
| Dec 11, 2017 | Niemann Bradley V. | President Biostim | Form 4 sale | 5,547 | $289k | 13.8% | Plan not stated | SEC |
| Nov 28, 2017 | Mason Brad | CEO | Form 4 sale | 5,000 | $267k | 2.7% | Plan not stated | SEC |
| Nov 6, 2017 | Faulstick Luke T | Director | Form 4 sale | 4,800 | $246k | 38.3% | Unusual | SEC |
| Sep 11, 2017 | Niemann Bradley V. | President Biostim | Form 4 sale | 6,956 | $344k | 14.8% | Plan not stated | SEC |
| Sep 11, 2017 | Doug Rice | CFO | Form 4 sale | 7,353 | $364k | 14.1% | Plan not stated | SEC |
| Aug 21, 2017 | Mason Brad | CEO | Form 4 sale | 2,733 | $131k | 1.4% | Plan not stated | SEC |
| Aug 10, 2017 | Fujikawa Raymond | President Spine Fixation | Form 4 sale | 6,364 | $299k | 17.0% | Plan not stated | SEC |
| Nov 10, 2016 | Mason Brad | CEO | Form 4 sale | 9,538 | $351k | 6.1% | Plan not stated | SEC |
| Sep 1, 2016 | Finegan Michael | Chief Strategy Officer | Form 4 sale | 25,000 | $1.1M | 37.5% | Unusual | SEC |
| Jun 10, 2016 | Sainz Maria | Director | Form 4 sale | 4,157 | $193k | 16.6% | Plan not stated | SEC |
| Jun 9, 2016 | Mason Brad | CEO | Form 4 sale | 18,336 | $843k | 11.4% | Plan not stated | SEC |
| Jun 8, 2016 | Niemann Bradley V. | President Biostim | Form 4 sale | 3,402 | $152k | 11.8% | Plan not stated | SEC |
| May 20, 2016 | Goodwin Robert Allen II | President Biologics | Form 4 sale | 13,187 | $580k | 32.1% | Unusual | SEC |
| Apr 18, 2016 | Finegan Michael | Chief Strategy Officer | Form 4 sale | 80,972 | $3.5M | 67.6% | Unusual | SEC |
| Nov 11, 2015 | Finegan Michael | Chief Strategy Officer | Form 4 sale | 14,140 | $594k | 19.5% | Plan not stated | SEC |
| Nov 6, 2015 | Schumm Jeffrey | Chief Administrative Officer | Form 4 sale | 15,000 | $610k | 17.9% | Plan not stated | SEC |
| Nov 6, 2015 | Mason Brad | CEO | Form 4 sale | 15,018 | $610k | 9.7% | Plan not stated | SEC |
| May 21, 2015 | Scoon Davey | Director | Form 4 sale | 5,709 | $185k | 34.3% | Unusual | SEC |
| Aug 20, 2012 | Ferrari Luigi | President, Orthopedics | Form 4 sale | 19,270 | $798k | 54.9% | Unusual | SEC |
| Aug 16, 2012 | Ferrari Luigi | President, Orthopedics | Form 4 sale | 7,757 | $320k | 32.9% | Unusual | SEC |
| Aug 15, 2012 | Finegan Michael | President, Biologics | Form 4 sale | 7,000 | $287k | 22.7% | Plan not stated | SEC |
| Aug 13, 2012 | Ferrari Luigi | President, Orthopedics | Form 4 sale | 1,300 | $55k | 6.3% | Plan not stated | SEC |
| Aug 10, 2012 | Finegan Michael | President, Biologics | Form 4 sale | 10,000 | $418k | 29.5% | Unusual | SEC |
| Aug 3, 2012 | Finegan Michael | President, Biologics | Form 4 sale | 11,700 | $490k | 32.9% | Unusual | SEC |
| Aug 3, 2012 | Ferrari Luigi | President, Orthopedics | Form 4 sale | 329 | $14k | 1.7% | Plan not stated | SEC |
| Aug 2, 2012 | Finegan Michael | President, Biologics | Form 4 sale | 3,300 | $135k | 12.2% | Plan not stated | SEC |
| May 3, 2012 | Lee Brad | President, Sports Medicine GBU | Form 4 sale | 20,617 | $834k | 76.1% | Unusual | SEC |
| May 2, 2012 | Lee Brad | President, Sports Medicine GBU | Form 4 sale | 14,811 | $603k | 69.6% | Unusual | SEC |
| Nov 30, 2011 | Ferrari Luigi | President,Orthopedics | Form 4 sale | 21,239 | $727k | 100.0% | Unusual | SEC |
| Feb 23, 2011 | Ferrari Luigi | President, Orthopedics | Form 4 sale | 1,741 | $54k | 17.9% | Plan not stated | SEC |
| May 17, 2010 | Ferrari Luigi | President, Int'l Fixation | Form 4 sale | 1,497 | $51k | 100.0% | Unusual | SEC |
| Mar 11, 2010 | Brown Eric | President, Spinal Stimulation | Form 4 sale | 6,667 | $237k | 57.1% | Unusual | SEC |
| Mar 10, 2010 | Lee Brad | President, Breg, Inc. | Form 4 sale | 2,037 | $72k | 64.2% | Unusual | SEC |
| Mar 10, 2010 | Brown Eric | President, Spinal Stimulation | Form 4 sale | 10,803 | $383k | 68.4% | Unusual | SEC |
| Mar 10, 2010 | Ferrari Luigi | President,Int'l Fixation | Form 4 sale | 955 | $34k | 100.0% | Unusual | SEC |
| Nov 9, 2007 | Mason Bradley R | President, Breg | Form 4 sale | 25,000 | $1.4M | 25.0% | Unusual | SEC |
| Nov 5, 2007 | Hewett Peter J | Director | Form 4 sale | 2,875 | $151k | 4.6% | Plan not stated | SEC |
| Oct 29, 2007 | Hewett Peter J | Director | Form 4 sale | 5,750 | $305k | 9.1% | Plan not stated | SEC |
| Oct 22, 2007 | Hewett Peter J | Director | Form 4 sale | 5,750 | $296k | 9.9% | Plan not stated | SEC |
| Oct 15, 2007 | Hewett Peter J | Director | Form 4 sale | 5,750 | $290k | 10.7% | Plan not stated | SEC |
| Oct 8, 2007 | Hewett Peter J | Director | Form 4 sale | 5,750 | $287k | 11.8% | Plan not stated | SEC |
| Oct 1, 2007 | Hewett Peter J | Director | Form 4 sale | 2,875 | $139k | 7.0% | Plan not stated | SEC |
| Sep 24, 2007 | Hewett Peter J | Director | Form 4 sale | 2,875 | $134k | 7.4% | Plan not stated | SEC |
| Sep 17, 2007 | Hewett Peter J | Director | Form 4 sale | 2,875 | $131k | 8.5% | Plan not stated | SEC |
| Sep 11, 2007 | Hein Thomas M | Chief Financial Officer | Form 4 sale | 7,500 | $354k | 67.3% | Unusual | SEC |
| Aug 20, 2007 | Hein Thomas M | Chief Financial Officer | Form 4 sale | 15,000 | $709k | 80.5% | Unusual | SEC |
| May 31, 2007 | Mason Bradley R | President, Breg | Form 4 sale | 22,674 | $1.1M | 18.5% | Plan not stated | SEC |
| May 22, 2007 | Mason Bradley R | President, Breg | Form 4 sale | 20,000 | $928k | 14.0% | Plan not stated | SEC |
| May 17, 2007 | Mason Bradley R | President, Breg | Form 4 sale | 10,000 | $464k | 6.5% | Plan not stated | SEC |
| May 14, 2007 | Mason Bradley R | President, Breg | Form 4 sale | 5,000 | $236k | 3.2% | Plan not stated | SEC |
| Apr 18, 2007 | Gaines Cooper Robert | 10% owner | Form 4 sale | 9,500 | $482k | 2.6% | Plan not stated | SEC |
| Apr 18, 2007 | Gaines Cooper Robert | 10% owner | Form 4 sale | 17,468 | $877k | 4.6% | Plan not stated | SEC |
| Apr 17, 2007 | Gaines Cooper Robert | 10% owner | Form 4 sale | 19,432 | $972k | 4.9% | Plan not stated | SEC |
| Apr 13, 2007 | Gaines Cooper Robert | 10% owner | Form 4 sale | 3,100 | $155k | 0.8% | Plan not stated | SEC |
| Apr 10, 2007 | Gaines Cooper Robert | 10% owner | Form 4 sale | 15,000 | $762k | 3.6% | Plan not stated | SEC |
| Apr 5, 2007 | Gaines Cooper Robert | 10% owner | Form 4 sale | 15,000 | $769k | 3.5% | Plan not stated | SEC |
| Mar 12, 2007 | Mason Bradley R | President, Breg | Form 4 sale | 10,000 | $495k | 6.0% | Plan not stated | SEC |
| Dec 22, 2006 | Gaines Cooper Robert | Director, 10% owner | Form 4 sale | 81,700 | $3.8M | 20.4% | Plan not stated | SEC |
| Dec 5, 2006 | Federico Charles | Director | Form 4 sale | 43,800 | $2M | 91.0% | Unusual | SEC |
| Aug 31, 2006 | Federico Charles | Director | Form 4 sale | 250,000 | $9.9M | 98.3% | Unusual | SEC |
| Mar 17, 2006 | Henley Gary | President, Americas Division | Form 4 sale | 4,834 | $197k | 85.5% | Unusual | SEC |
| Mar 10, 2006 | Gaines Cooper Robert | Director, 10% owner | Form 4 sale | 800 | $33k | 0.2% | Plan not stated | SEC |
| Mar 9, 2006 | Gaines Cooper Robert | Director, 10% owner | Form 4 sale | 19,200 | $808k | 4.3% | Plan not stated | SEC |
| Mar 8, 2006 | Federico Charles | President & CEO | Form 4 sale | 2,500 | $108k | 36.6% | Unusual | SEC |
| Mar 3, 2006 | Federico Charles | President & CEO | Form 4 sale | 3,100 | $135k | 41.8% | Unusual | SEC |